FDA-Inspected Site

Aarkish Pharmaceuticals NJ Inc

3 FDA inspections are on record for Aarkish Pharmaceuticals NJ Inc in Fairfield, United States.

483· Form 483 issued

Fairfield, United States · Last updated July 11, 2026

Overview

  • 3 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-10-24.

At a glance

Inspections

3

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
20 Oct 2025 – 24 Oct 2025Human Drugs483View 483 →
20 Sep 2023 – 26 Sep 2023Human DrugsClean
8 Aug 2022 – 18 Aug 2022Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

24 Oct 2025
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Luxuly Abraham

24 Oct 2025
21 CFR 211.63

Equipment Design, Size and Location

Cited by Luxuly Abraham

18 Aug 2022
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Junho Pak, Jessica S Estriplet, Karen A Briggs

18 Aug 2022
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Junho Pak, Jessica S Estriplet, Karen A Briggs

18 Aug 2022
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Junho Pak, Jessica S Estriplet, Karen A Briggs

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.68(b)Cited across public-safe Form 483 observations4x
21 CFR 211.63Cited across public-safe Form 483 observations3x
21 CFR 211.100(a)Cited across public-safe Form 483 observations2x
21 CFR 211.142(b)Cited across public-safe Form 483 observations2x
21 CFR 211.188(a)Cited across public-safe Form 483 observations2x
21 CFR 211.194(a)Cited across public-safe Form 483 observations2x
21 CFR 211.46(b)Cited across public-safe Form 483 observations2x
21 CFR 211.67(b)Cited across public-safe Form 483 observations2x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Aarkish Pharmaceuticals NJ Inc's 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat